Sensome's Smart Stylet Shows Promise in Lung Cancer Biopsy Accuracy
Sensome has announced positive results from its first-in-human INSPECT study, which evaluated its smart stylet technology for bronchoscopic lung biopsy. The study, presented at the American Thoracic Society meeting in Orlando, Florida, demonstrated that the smart stylet could accurately differentiate between cancerous and healthy lung tissue. The technology, which integrates a microsensor into a conventional stylet, aims to improve biopsy accuracy by confirming the placement of the biopsy tool within a tumor. In the study involving 27 patients, the smart stylet achieved an 80.9% accuracy rate in distinguishing healthy from abnormal lung tissue, with a sensitivity of 88.5% and specificity of 71.4%. It also showed a 78.7% accuracy rate in differentiating cancer from other tissue types, with a sensitivity of 78.3% and specificity of 79.2%. 
